	Physician- and Patient-Reported Outcomes Following Contemporary Image Guided Intensity Modulated Proton Therapy for Prostate Cancer: Results From the Prospective PRO-Cube Study. Adv Radiat Oncol Sundar S, Chilukuri S, Arjunan M, Kamath R, Sinha A, Palani M, Panda PK, Mullapally SK, Ramani S, Ragavan N, Jawahar P, Amalachandran J, Sharma DS, Jalali R. PMID: 42657230 [PubMed]
	Association between serum preptin levels and bone metastasis in newly diagnosed prostate cancer: a prospective exploratory study. J Bone Oncol Gülba, Akda, Gül D, Halis H, Engin EO, Çimen H, Hac. PMID: 42656999 [PubMed]
	Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial. Future Oncol Di Franco R, Mercogliano S, Mottareale R, Borzillo V, Scipilliti E, Serra M, Buonanno F, Ametrano G, Perrone F, Piccirillo MC, Pignata S, Rossetti S, Perdonà S, Franzese D, Izzo A, Muscariello R, Grimaldi G, Castaldo L, Lastoria S, Di Gennaro F, Raddi M, Petrillo A, Simonetti I, Cavalcanti E, De Falco R, di Franco MA, Maiolino P, Pagliuca MI, Roberta D, Vincenzo R. PMID: 42656189 [PubMed - as supplied by publisher]
	Extended Versus Non-Extended Lymphadenectomy in Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. J Surg Oncol Azevedo MFD, Brito PHS, Kallas-Silva L, Liebl B, Constantinou BT, Benedicto BC, Oliveira LP, Cordeiro MD, Nahas WC, Shabana W, Shahrour W, Ribeiro-Filho LA, Suartz CV. PMID: 42655992 [PubMed - as supplied by publisher]
	Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery. Int J Urol Yanagida K, Takada I, Ishida T, Takei K, Kishitani K, Minagawa H, Kawai T, Kaneko T, Sasajima Y, Nakagawa T. PMID: 42655970 [PubMed - indexed for MEDLINE]
	Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy. Int J Urol Özberk U, Perkin P, Ye, Alg, Karaka, Ak, Uçar G. PMID: 42655932 [PubMed - indexed for MEDLINE]
	Outcomes and Predictive Factors for Gynecologic Organ Involvement in Radical Cystectomy for Female Bladder Cancer Patients: A Multicenter Retrospective Cohort Study. Medicina (Kaunas) Arikan MG, Arda E, , Yilmaz H, Suer E, Akgul M, Yazici S, Bolat D, Aslan G, Akan S, Turkeri L. PMID: 42654506 [PubMed - indexed for MEDLINE]
	Integrated Inflammatory and Nutritional Biomarkers in Metastatic Renal Cell Carcinoma Treated with Second- or Later-Line Nivolumab: A Retrospective Cohort Study. Medicina (Kaunas) U, Kerimo, Koçak MZ, Aykut T, Ça, Karakurt Ery, Araz M, Artaç M. PMID: 42654418 [PubMed - indexed for MEDLINE]
	Clinicopathological Analysis of Prostate Cancer in Young Men: Experience of a Tertiary Referral Hospital in Western Romania. Medicina (Kaunas) Dema V, Croitor A, Barna RA, Dema S, T, Nanu M, Mîrnea D, C, Bardan R, Cump. PMID: 42654362 [PubMed - indexed for MEDLINE]
	Gold Nanoparticles in Prostate Cancer: Advances in Targeted Therapy, Diagnostics, and Precision Nanomedicine. Pharmaceuticals (Basel) Hani U, Hamod MA, Hamood NA, Alhamhoom Y, Ghazwani M, AlQahtani F, Helal HA, Osmani RAM. PMID: 42653769 [PubMed]
	Human Group IIA Secreted Phospholipase A(2) and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms. Int J Mol Sci Andarva M, Elias MG, Sajinovic M, Roberts TL, de Souza P, Scott KF. PMID: 42653281 [PubMed - indexed for MEDLINE]
	Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review. Int J Mol Sci Murray NP. PMID: 42653263 [PubMed - indexed for MEDLINE]
	Integrated Mendelian Randomization and Single-Cell Transcriptomics Reveal T Cell Immune Mechanisms in Systemic Lupus Erythematosus-Bladder Cancer Comorbidity. Life (Basel) Zhang D, Ren H, Bai Y, Han P. PMID: 42653069 [PubMed]
	SARIFA and Lipid Metabolic Reprogramming in Prostate Cancer: Fundamental Mechanisms, Tumor Microenvironment, and Novel Biomarker Prospects. Life (Basel) Mikhaleva L, Martynova M, Gioeva Z, Shakhpazyan N, Chizhikov N, Pechnikova V, Gushchin M, Ilyichev A. PMID: 42652992 [PubMed]
	Reprogramming the Evolution of High-Risk Prostate Cancer: Multidisciplinary Strategies to Delay Castration Resistance. J Clin Med Sim Y, Choi JW, Kim DS, Kim JH, Yoon SG, Jo JK. PMID: 42652891 [PubMed]
	Long-Term Follow-Up of the Reliability, Accuracy, and Morbidity of Dynamic Sentinel Lymph Node Biopsy in Patients with Intermediate- and High-Risk Penile Cancer and Clinically Negative Lymph Node Status. J Clin Med Pytel Á, Pytel B, Semjén D, Ritter Z. PMID: 42652853 [PubMed]
	Hyperthermic Intravesical Chemotherapy as a Bladder-Sparing Alternative to BCG in the Management of Non-Muscle-Invasive Bladder Cancer: A Systematic Review of Oncological Outcomes in the Era of BCG Shortage. J Clin Med Croitor A, Cadariu-Brailoiu V, Zbircea AD, Bardan R, Dema V, Dema S, Dema A, Cumpanas A. PMID: 42652756 [PubMed]
	Imaging and Clinical Correlates of [(177)Lu]Lu-PSMA PET-Defined Eligibility in De Novo Metastatic Prostate Cancer. Biomedicines Pecoraro G, Cuzzocrea M, Iacovitti CM, Puglisi M, Martinello C, De Giorgi A, Merler S, Tortola L, Lin HM, Leone G, Turco F, Mestre RP, Treglia G, Vogl U, Gillessen S, Pedrani M, Paone G. PMID: 42652200 [PubMed]
	SUMOylation-Driven Subtype Heterogeneity and Prognostic Biomarkers in Renal Cell Carcinoma. Curr Issues Mol Biol Zhang X, Li Z, Lin R, Yang S, Sun X, Chen S. PMID: 42651750 [PubMed]
	Optical Spectroscopy and Spectral Imaging for Bladder Cancer Detection and Characterisation: A Scoping Review of Diagnostic Evidence and Translational Readiness. Diagnostics (Basel) Vander Stichele A, Van Cleynenbreugel B. PMID: 42650964 [PubMed]

Articles 1 - 20 / 181032

Page 1 of 9052



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy